CDKN2A exhibited oncogenic features, the overexpression of which was associated with worse survival in ccRCC patients (HR = 1.21 (1.01–1.45), p = 3.52 × 10−2, Table S2). This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.